-
公开(公告)号:EP1434860A2
公开(公告)日:2004-07-07
申请号:EP02783990.1
申请日:2002-09-26
发明人: YANG, Junming , LU, Dyung Aina, M. , YUE, Henry , ELLIOTT, Vicki, S. , WARREN, Bridget, A. , DUGGAN, Brendan, M. , FORSYTHE, Ian, J. , LEE, Ernestine, A. , HAFALIA, April, J.A. , RAMKUMAR, Jayalaxmi , CHAWLA, Narinder, K. , BAUGHN, Mariah, R. , BECHA, Shanya, D. , GORVAD, Anne, E. , TRAN, Uyen, K. , LI, Joana, X. , YAO, Monique, G. , ISON, Craig, H. , GRIFFIN, Jennifer, A. , CHANG, Hsin-Ru , EMERLING, Brooke, M. , TANG, Y. Tom , LAL, Preeti G. , KABLE, Amy E. , MARQUIS, Joseph P. , JIANG, Xin , JACKSON, Alan A. , ZEBARJADIAN, Yeganeh , SWARNAKAR, Anita , WILSON, Amy D. , JIN, Pei , RICHARDSON, Thomas W. , BHATIA, Umesh , BURRILL, John C. , LEE, Sally , BLAKE, Julie J. , HO, Anne , ZHENG, Wenjin , GAO, Jing , LEE, Soo Yeun
CPC分类号: C07K14/4702 , A61K38/00 , C12N9/20
摘要: Various embodiments of the invention provide human enzymes (ENZM) and polynucleotides which identify and encode ENZM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of ENZM.